First Circuit Rejects Whistleblower’s Fraud on the FDA FCA Theory
In a recent decision, the First Circuit rejected a relator’s claim that a medical device manufacturer caused the submission of false claims for Medicare reimbursement by fraudulently obtaining Food and Drug Administration approval of one of its devices.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.